1) Oberoi S, Lehrnbecher T, Phillips B, et al:Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis:a systematic review and metaanalysis. Leuk Res 2014;38:460-8 2) Giles FJ, Shen Y, Kantarjian HM, et al:Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 200;42:67-73 3) Bug G, Anargyrou K, Tonn T, et al:Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 2007;47:1843-50 4) Porcu P, Farag S, Marcucci G, et al:Leukocytoreduction for acute leukemia. Ther Apher 2002;6:15-23 5) Choi MH, Choe YH, Park Y, et al:The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis:a propensity score-matched study. Transfusion 2018;58:208-16 6) Nguyen R, Jeha S, Zhou Y, et al:The role of leukapheresis in the current management of hyperleukocytosis in newly diagnosed childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2016;63:1546-51 7) Creutzig U, Rössig C, Dworzak M, et al:Exchange transfusion and leukapheresis in pediatric patients with AML with high risk of early death by bleeding and leukostasis. Pediatr Blood Cancer 2016;63:640-5 8) Kuo KH, Callum JL, Panzarella T, et al:A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. Br J Haematol 2015;168:384-94